Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

A study to assess the role of nurse navigator among adult cancer patients attending out patient unit of tertiary care cancer hospital.

ABSTRACT: Intervention1: NAV- GISM NAVIGATION MODEL: Nurse led navigation among adult GI cancer patients. Control Intervention1: Control group: Gastro Intestinal cancer patients getting usual care in the system Control Intervention2: Intervention group: Gastro Intestinal cancer patients receiving NAV GISM intervention for 15-20 minutes, two times at 3 week gap. Primary outcome(s): Patient satisfaction, treatment adherence, anxietyTimepoint: Patient satisfaction, treatment adherence, anxiety at baseline and at 9 weeks.

DISEASE(S): Malignant Neoplasm Of Rectum,Malignant Neoplasm Of Small Intestine,Malignant Neoplasm Of Rectosigmoidjunction,Malignant Neoplasm Of Stomach,Malignant Neoplasm Of Gallbladder,Malignant Neoplasm Of Anus And Anal Canal,Malignant Neoplasm Of Pancreas,Malignant Neoplasm Of Liver And Intrahepatic Bile Ducts,Malignant Neoplasm Of Colon,Malignant Neoplasm Of Esophagus

PROVIDER: 2757803 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

ACCESS DATA

Json Xml

Similar Datasets

a4e4179e-1381-42ed-8fd2-883dbf55c9a9 - samples

Project description:This dataset entails 40 Bulk-RNA sequenced patient-derived gastro-intestinal neuroendocrine (GEP-NEN) neoplasms.

| EGAD00001006657 | EGA

Guduchyadi Karma Basti (enema) and Rasayana Avaleha used for treatment of Cancer

Project description:Intervention1: Guduchyadi karma Basti: Guduchyadi karma Basti combination of Guduchi grita anuvasana basti 100 to 120 ml and guduchyadi niruha basti 600 to 800 mal for 30 days in gastro intestinal cancer Intervention2: Guduchyadi karma Basti along with rasayana Avaleha: Guduchyadi karma Basti combination of Guduchi grita anuvasana basti 100 to 120 ml and guduchyadi niruha basti 600 to 800 mal for 30 days along with rasayana avaleha30gm per day for 30 days in gastro intestinal canc Control Intervention1: modern cancer treatment: palliative conservative medicine for cancer treatment or in follow up in cancer treatment Primary outcome(s): efficacyTimepoint: prospective Study Design: Randomized, Parallel Group, Active Controlled Trial Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:An Open list of random numbers Blinding and masking:Open Label

| 2588744 | ecrin-mdr-crc

Whole genome bisulfite sequencing (WGBS) of intestinal organoids from mice with graft-versus-host disease

Project description:Intestinal stem cells (ISC) encounter inflammatory insults in immune mediated gastro-intestinal (GI) diseases. It remains unknown whether, and how, they adapt, and if the adaptation leaves scars on the ISCs that affects their subsequent regeneration capacity. We investigated the consequences of inflammation on Lgr5+ISCs in well-defined clinically relevant models of gastro-intestinal acute graft-versus-host disease (GI GHD). We investigated the consequences of inflammation on Lgr5+ISCs in well-defined clinically relevant models of gastro-intestinal acute graft-versus-host disease (GI GVHD). Utilizing single cell transcriptomics, organoid, metabolic, epigenomic and in vivo models we found that Lgr5+ISCs undergo metabolic changes that lead to accumulation of succinate, which reprograms its epigenome. These changes reduced the ability of ISCs to differentiate and regenerate ex vivo in serial organoid cultures demonstrating the persistence of the maladaptive impact of an in vivo inflammatory encounter by the ISCs. Thus, inflammation from GI GVHD leaves a memory of its effects on ISCs that persist and are likely to affect their sensitivity to adapt to future stress or challenges.

2024-09-11 | GSE243364 | GEO

INTESTINAL FILTER FOR USE IN OESOPHAGEAL CANCER RESEARCH

Project description:This study utilise the examination of normal gastro-intestinal tissues to determine a tissue specific signal for use in deriving the intestinal signature of intestinal metaplasias of the oesophagus. Normal oesophageal, colonic and duodenal tissue biopsies were taken after informed consent and RNA was extracted following histological examination of adjacent tissues for normal aperaing mucosa. Three of each tissue type

2013-07-07 | E-GEOD-40220 | biostudies-arrayexpress

Epigenetic changes from ATAC-seq of intestine stem cells from mice with graft-versus-host disease

2024-09-11 | GSE223814 | GEO

INTESTINAL FILTER FOR USE IN OESOPHAGEAL CANCER RESEARCH

2013-07-07 | GSE40220 | GEO

Gene expression profile at single cell level of intestine stem cells from mice with graft-versus-host disease

Project description:Intestinal stem cells (ISC) encounter inflammatory insults in immune mediated gastro-intestinal (GI) diseases. It remains unknown whether, and how, they adapt, and if the adaptation leaves scars on the ISCs that affects their subsequent regeneration capacity. We investigated the consequences of inflammation on Lgr5+ISCs in well-defined clinically relevant models of gastro-intestinal acute graft-versus-host disease (GI GHD). Utilizing single cell transcriptomics, organoid, metabolic, epigenomic and in vivo models we found that Lgr5+ISCs undergo metabolic changes that lead to accumulation of succinate, which reprograms its epigenome. Single cells were isolated from small intestine crypts from Allo (BALB/c→C57BL/6) or Syn (C57BL/6→C57BL/6) transplant 7 days after bone marrow transplantation (BMT) and analyzed using scRNA-seq.

2024-09-11 | GSE223368 | GEO

Homo sapiens

Project description:Biomarkers of human gastro-intestinal tract regions

| PRJNA107369 | ENA

Broiler gastro-intestinal microbiome

Project description:Broiler gastro-intestinal microbiome Raw sequence reads

| PRJNA836733 | ENA

Project description:gastro-intestinal tract flora of Babylonia areolata

| PRJNA737559 | ENA